Store below 25C, avoiding light and freezing for optimal potency
Before prescribing anything, they completed extensive blood work to rule out underlying medical issues that could have been preventing weight loss
Loading Phase (Weeks 1 through 4) Tb-500: 2 to 2.5 mg twice weekly (Monday and Thursday) totaling 4 to 5 mg per week Bpc-157: 0.5 mg daily, either as single dose or split into 0.25 mg twice daily Maintenance Phase (Weeks 5 through 8 plus) Tb-500: 2 mg once weekly Bpc-157: 0.25 to 0.5 mg daily Critical Notes Use separate vials and syringes for each peptide Never mix Bpc-157 and Tb-500 in the same syringe Tb-500 can be injected anywhere subcutaneously Bpc-157 should ideally be injected near the injury site The critical implementation detail bears repeating: Bpc-157 and Tb-500 should never be combined into a single vial as peptides lose their effectiveness when mixed incorrectly
Moreover, neuropathological examination of MS tissue indicates that degeneration, CNS atrophy, and myelin loss are most prominent in the progressive stage, when lymphocytic inflammation paradoxically wanes
The theoretical concern about its pro-angiogenic properties hasn't been validated by experimental data
This medication is best for people with obesity and overweight who want to reduce body weight, control blood sugar in patients with type 2 diabetes, and manage weight-related complications such as moderate to severe obstructive sleep apnea
